Author Archives: CS

Introduction: In pharmaceutical quality control, two terms often raise red flags during testing: Out of Specification (OOS) and Out of Trend (OOT). Both are critical indicators of product quality, regulatory compliance, and patient safety. While OOS points to immediate failures against defined standards, OOT highlights subtle deviations from expected patterns. Understanding, investigating, and preventing theseContinue reading “Out of Specification and Out of Trend in Pharmaceutical Analysis”

Introduction: In the pharmaceutical industry, regulatory compliance is non-negotiable. 21 CFR Part 11 is one of the most critical FDA regulations for digital systems. It governs the use of electronic records and electronic signatures. As pharma companies increasingly adopt cloud-based platforms and paperless workflows, understanding and implementing Part 11 is essential for data integrity, auditContinue reading “CFR Part 11 Compliance in Pharma — A Complete Guide for 2025”

GAMP, or Good Automated Manufacturing Practice, is a set of guidelines and best practices for designing, implementing, and maintaining automated systems in the pharmaceutical industry. Developed by the International Society for Pharmaceutical Engineering (ISPE), GAMP aims to ensure that automated systems used in the production of pharmaceutical products are compliant with regulatory requirements and maintainContinue reading “GAMP in Pharmaceutical Industry”

Analytical Method Transfer (AMT) is the process of transferring analytical procedures and methodologies from one laboratory to another. Consequently, this ensures consistency, reliability, and regulatory compliance in drug development and manufacturing processes. This transfer is typically done to ensure consistency, reliability, and regulatory compliance in drug development and manufacturing processes. Significance of AMT in PharmaceuticalContinue reading “Analytical Method Transfer (AMT) and its significance in pharmaceutical manufacturing”

Reduced study designs, in the context of pharmaceutical development and stability testing, refer to approaches that allow for a reduction in the number of samples and/or time points for testing while still ensuring the reliability and validity of the data. The concept of reduced study designs aligns with the guidelines provided by the ICH.. TheseContinue reading “Bracketing and Matrixing Designs for Stability Testing”

Regulatory bodies in the pharmaceutical industry play a crucial role in ensuring the safety, efficacy, and quality of pharmaceutical products. Here are some of the key regulatory bodies from various regions around the world: These are just a few examples, and many other countries have their regulatory agencies to oversee the pharmaceutical industry. These agenciesContinue reading “Pharma Regulatory Bodies Worldwide”

Originating in the manufacturing industry, the “5 Whys” analysis technique has found effective adaptation and application in various fields, including pharmaceuticals. It involves asking “why” multiple times (typically five) to dig deeper into the root causes of a problem. In the context of pharmaceuticals, the 5Whys tool can help identify the underlying causes of qualityContinue reading “5 Why tools for Root cause analysis in pharmaceuticals”

ELSD stands for Evaporative Light Scattering Detector. It serves as a type of analytical instrument in chromatography for detecting and quantifying non-volatile compounds lacking a natural chromophore or fluorophore. It proves especially valuable when analyzing compounds that UV, fluorescence, or conductivity detectors, commonly used in chromatography, cannot detect. How ELSD Works: Applications of ELSD: InContinue reading “Evaporative Light Scattering Detector(ELSD)”